These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3580507)

  • 21. Angiogenesis in the bone marrow of patients with breast cancer.
    Chavez-Macgregor M; Aviles-Salas A; Green D; Fuentes-Alburo A; Gómez-Ruiz C; Aguayo A
    Clin Cancer Res; 2005 Aug; 11(15):5396-400. PubMed ID: 16061853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of lipid-associated sialic acid (LSA) and prostate specific antigen (PSA) in the follow-up of prostatic cancer.
    Meyer U; Dierig C; Katopodis N; De Bruijn CH
    Anticancer Res; 1993; 13(5C):1889-94. PubMed ID: 7505544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer.
    Janku F; Kleibl Z; Novotny J; Tesarova P; Petruzelka L; Matous B
    Neoplasma; 2004; 51(3):204-8. PubMed ID: 15254674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid associated sialic acid in plasma in patients with advanced carcinoma of the ovaries.
    Vardi JR; Tadros GH; Malhotra C; Charney T; Shebes M; Foemmel R
    Surg Gynecol Obstet; 1989 Apr; 168(4):296-301. PubMed ID: 2928903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival.
    Benoy IH; Salgado R; Van Dam P; Geboers K; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Clin Cancer Res; 2004 Nov; 10(21):7157-62. PubMed ID: 15534087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microsatellite alterations plasma DNA of primary breast cancer patients.
    Shaw JA; Smith BM; Walsh T; Johnson S; Primrose L; Slade MJ; Walker RA; Coombes RC
    Clin Cancer Res; 2000 Mar; 6(3):1119-24. PubMed ID: 10741742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
    Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS
    Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
    Li BJ; Wang JY; Wang HY; Huang XP; Zhang LJ; Long H; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):766-9. PubMed ID: 17366790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total and lipid-bound serum sialic acid in benign and malignant breast disease.
    Romppanen J; Eskelinen M; Tikanoja S; Mononen I
    Anticancer Res; 1997; 17(2B):1249-53. PubMed ID: 9137482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of micrometastases in bone marrow in patients with primary breast cancer.
    Coombes RC; Berger U; Mansi J; Redding H; Powles TJ; Neville AM; McKinna A; Nash AG; Gazet JC; Ford HT
    NCI Monogr; 1986; (1):51-3. PubMed ID: 3774015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer.
    Pantel K; Izbicki JR; Angstwurm M; Braun S; Passlick B; Karg O; Thetter O; Riethmüller G
    Cancer Res; 1993 Mar; 53(5):1027-31. PubMed ID: 7679945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of micrometastatic disease in bone marrow: is it ready for prime time?
    Janni W; Rack B; Lindemann K; Harbeck N
    Oncologist; 2005 Aug; 10(7):480-92. PubMed ID: 16079315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.
    Wiedswang G; Borgen E; Kåresen R; Kvalheim G; Nesland JM; Qvist H; Schlichting E; Sauer T; Janbu J; Harbitz T; Naume B
    J Clin Oncol; 2003 Sep; 21(18):3469-78. PubMed ID: 12972522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
    Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tumor biology of primary breast cancer and minimal residual disease].
    Schindlbeck C; Janni W; Schaffer P; Shabani N; Schmitt M; Harbeck N; Sommer H; Braun S
    Acta Med Austriaca Suppl; 2002; 59():27-31. PubMed ID: 12506757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: sensitivity in a model system.
    Osborne MP; Asina S; Wong GY; Old LJ; Cote RJ
    Cancer Res; 1989 May; 49(9):2510-3. PubMed ID: 2650865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.
    Musset M; Mathé G; Reizenstein P
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():17-20. PubMed ID: 3249552
    [No Abstract]   [Full Text] [Related]  

  • 38. Monitoring and treatment of minimal residual cancer of the prostate.
    Mathé G; Schally AV; Comaru-Schally AM; Mauvernay RY; Vovan ML; Machover D; Misset JL; Court B; Bouchard P; Duchier J
    Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):65-74. PubMed ID: 2525968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
    Schutter EM; Visser JJ; van Kamp GJ; Mensdorff-Pouilly S; van Dijk W; Hilgers J; Kenemans P
    Tumour Biol; 1992; 13(3):121-32. PubMed ID: 1626178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of total (TSA) and lipid and bound (LSA) sialic acid levels with cytology of cyst or body fluids in cancer patients.
    Chondros K; Dapolla V; Stringou E; Petiniki M; Vakouftsi M; Kakari S
    Anticancer Res; 1991; 11(6):2103-6. PubMed ID: 1776847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.